World-first 3D printed esophageal stents developed by the University of South Australia could revolutionize the delivery of chemotherapy drugs to provide more accurate, effective and personalized treatment for patients with esophageal cancer.
Fabricated from polyurethane filament and incorporating the chemotherapy drug 5-fluorouracil (5-FU), the new oesophageal stents are the first to contain active pharmaceutical ingredients within their matrix.
Their unique composition allows them to deliver up to 110 days of a sustained anti-cancer medication directly to the cancer site, restricting further tumor growth.